Arkolith/Insider Trading/ACAD/Form 4

Thompson Elizabeth H.Z.

EVP, Head of Research & DevACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Mar 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$74K
Net Open-Market Flow
-$74K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2026Sell(S)3K$21.47$74K3K
Mar 24, 2026Option exercise(M)7K——7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2026Option exercise(M)7K—$020K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001861477-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML